套管市场 - 全球产业规模、份额、趋势、机会及预测（按产品、类型、材料、尺寸、最终用途产业、地区及竞争格局划分，2021-2031年）

全球插管市场预计将从 2025 年的 2.2659 亿美元成长到 2031 年的 3.5778 亿美元，复合年增长率为 7.91%。

套管是柔软的管子，通常带有可扩张的内腔，对于排放流体腔和血管内的液体以及给药至关重要。该行业的主要驱动力是需要长期静脉治疗的慢性疾病的增加以及人口老化导致的住院率上升。此外，微创医疗技术的广泛应用也需要持续使用这些装置来进行精准的血管通路和液体管理，从而确保了不受市场短期波动影响的稳定需求。

儘管有这些成长要素，但导管相关血流感染的风险仍然是一个重大障碍，导致监管增加和医疗成本上升。疾病负担的显着指标也凸显了对更安全的血管通路解决方案的迫切需求。根据美国心臟协会发布的最新综合数据，2025年心血管疾病将导致全球约1,941万人死亡，凸显了需要医疗照护的患者数量庞大。

市场驱动因素

美容手术的日益普及是全球套管市场发展的关键催化剂，尤其推动了钝头微型套管的使用。这些专用器械正在取代传统的皮下注射针，用于软组织填充注射，因为它们可以减少内出血、减轻疼痛，并显着降低血管阻塞的风险。非侵入性领域的快速成长也促进了这一转变。根据国际美容整形外科学会于2025年6月发布的《2024年全球研究新闻稿》，预计全球整体非手术美容计画将增至约2,050万例。因此，製造商被迫开发柔软性、更安全的脸部轮廓塑形套管，从而在血管通路市场中开闢出一个盈利的细分领域。

同时，全球慢性文明病和呼吸系统疾病发生率的上升，使得持续的治疗性介入成为必要，从而确保了巨大的市场需求。糖尿病和慢性阻塞性肺病（COPD）等疾病需要频繁用药和持续性氧气疗法，这维持了对优质静脉导管和氧气鼻管的需求。例如，国际糖尿病联盟（IDF）发布的第11版《2025年IDF糖尿病地图集》估计，全球有5.89亿成年人患有糖尿病，这意味着有大量人群高度依赖胰岛素输注系统。这种广泛的疾病负担确保了医疗设备製造商的稳定收入。 ICU Medical在2025年11月发布的「2025年第三季财务业绩」中报告称，其季度收入约为5.37亿美元，证实了对关键输液和重症监护用品的持续需求。

市场挑战

导管相关血流感染和血管通路併发症的持续威胁仍然是全球套管市场发展的一大障碍。这项安全问题要求严格的法律规范，并增加了医疗机构的责任风险，从而显着限制了市场成长。随着监管机构实施更严格的安全通讯协定来应对这些风险，製造商被迫投入大量资源用于合规和品质保证，这增加了生产成本并延长了新器械的核准时间。这些财务和程序上的挑战提高了市场进入门槛，延缓了创新产品的上市，并有效地抑制了市场整体的发展速度。

临床环境中器械相关故障率居高不下，凸显了这项挑战的严峻性。根据2024年血管通路协会（AVA）的数据，住院病患週边静脉导管的故障率高达35%至50%。如此高的故障率迫使医疗机构投入大量资源用于併发症管理和重新置入手术。因此，医院往往采取保守的筹资策略，优先考虑全面检验而非大量采购，这直接阻碍了套管产品的快速普及和全球销售量成长。

市场趋势

医疗机関では、医疗従事者の职业上のリスクを低减するため、自动针保护技术を备えた安全IVカニューレの采用が标准化されつつあります。この动きは、医疗スタッフの针刺し事故を根絶し、血管アクセス过程における交差汚染を防止することを目的とした、より厳格な安全规制への直接的な対応です。これに対応し、メーカー各社は规制主导の防护工具需要を満たすため、生产能力を大幅に拡大しています。2025年1月のプレスリリース『BD、米国における重要医疗设备の製造を强化』によると、ベクトン・ディキンソン社は必须医疗提供要件を支援するため、安全设计注射デバイスの製造能力を40％以上増强する投资を発表しました。

同时，以居家照护为导向的易用型导管的研发正呈现出明显的趋势，尤其是在呼吸治疗和持续输注领域。随着医疗保健从医院向患者家中转移，人们对耐用、低维护的设备需求日益增长，这些设备能够帮助患者独立管理睡眠呼吸中止症和呼吸困难等慢性疾病。这种向居家照护的转变正推动专业设备製造商实现显着的收入成长。根据费雪派克医疗保健公司2025年5月发布的年度报告，该公司居家医疗产品系列（包括社区呼吸支持设备）的收入达到约7.4亿美元，比上一财年增长13%。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球套管市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产品（心臟科、皮肤科、鼻科、其他）
  • 按类型（新生儿插管、直型插管、带翼插管、带端口的翼插管、带止动器的翼插管）
  • 依材质（塑胶、金属、硅胶）
  • 依尺寸（14G、16G、18G、20G、22G、24G、26G）
  • 依最终使用者产业（医院、门诊手术中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美套管市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲套管市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区套管市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲套管市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲套管市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球套管市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic plc
• Becton Dickinson（BD）& Company
• Edward Lifesciences Corporation
• LivaNovaca plc
• Smiths Medical MD Inc
• Boston Scientific Corporation
• Hindustan Syringes and Medical Devices Ltd（HMD）
• Sterimedix Ltd.
• Angiplast Pvt. Ltd
• Sterimed Group

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Cannula Market is projected to expand from USD 226.59 Million in 2025 to USD 357.78 Million by 2031, exhibiting a CAGR of 7.91%. Defined as flexible tubes typically containing retractable inner cores, cannulas are essential for fluid drainage or medication administration within bodily cavities or vessels. The industry is primarily propelled by the increasing prevalence of chronic diseases requiring prolonged intravenous therapy and an aging population, which leads to higher hospitalization rates. Additionally, the widespread adoption of minimally invasive medical techniques mandates the consistent use of these devices for accurate vascular access and fluid management, ensuring a stable demand trajectory beyond temporary market shifts.

Despite these growth factors, the danger of catheter-related bloodstream infections constitutes a major obstacle, leading to tighter regulatory controls and increased healthcare expenses. This urgent necessity for safer vascular access solutions is reinforced by significant disease burden metrics; according to the American Heart Association's most recent comprehensive data from 2025, cardiovascular disease was responsible for roughly 19.41 million deaths worldwide, highlighting the massive volume of patients needing medical care.

Market Driver

The increasing popularity of aesthetic and cosmetic procedures has become a crucial catalyst for the global cannula market, particularly driving the use of blunt-tip microcannulas. These specialized instruments are being chosen over conventional hypodermic needles for soft tissue filler applications because they reduce patient bruising, alleviate pain, and significantly decrease the risk of vascular occlusion. This transition is supported by the rapid growth of the non-invasive sector; as per the International Society of Aesthetic Plastic Surgery's 'Global Survey 2024 Press Release' from June 2025, non-surgical interventions rose to approximately 20.5 million procedures globally. Consequently, manufacturers are compelled to develop flexible, safety-focused designs for facial contouring, establishing a lucrative niche within the vascular access market.

Concurrently, the escalating global incidence of chronic lifestyle and respiratory conditions demands sustained therapeutic interventions, securing the market's foundational volume. Diseases like diabetes and chronic obstructive pulmonary disease (COPD) necessitate frequent drug administration or continuous oxygen therapy, maintaining the requirement for superior intravenous and nasal cannulas. For example, the International Diabetes Federation's 'IDF Diabetes Atlas 11th Edition' in 2025 estimated that 589 million adults worldwide were living with diabetes, representing a demographic heavily dependent on insulin delivery mechanisms. This extensive disease burden guarantees reliable revenue for medical device firms; ICU Medical reported in their 'Third Quarter 2025 Financial Results' in November 2025 that quarterly revenues hit roughly $537 million, illustrating the persistent demand for vital infusion and critical care supplies.

Market Challenge

The ongoing threat of catheter-related bloodstream infections and complications associated with vascular access remains a significant hurdle to the Global Cannula Market's progress. This safety issue severely limits market growth by necessitating strict regulatory supervision and increasing liability risks for healthcare providers. As regulators implement more rigorous safety protocols to address these dangers, manufacturers must dedicate substantial resources to compliance and quality assurance, which drives up production costs and prolongs approval periods for new devices. These financial and procedural challenges establish high entry barriers and retard the launch of innovative products, effectively constraining the overall speed of market evolution.

The gravity of this challenge is emphasized by the high incidence of device-related failures in clinical environments. According to data from the Association for Vascular Access in 2024, the failure rate of peripheral intravenous catheters in hospitalized patients fell between 35% and 50%. Such a high rate of failure compels medical institutions to direct considerable funds toward managing complications and conducting re-insertion procedures. As a result, hospitals frequently employ conservative purchasing strategies that favor thorough validation over high volume, which directly inhibits the rapid uptake and global volume expansion of cannula products.

Market Trends

Healthcare institutions are increasingly standardizing the adoption of safety IV cannulas featuring automatic needle-shielding technology to reduce occupational risks. This movement is a direct reaction to more stringent safety regulations designed to eliminate needle-stick injuries among medical staff and prevent cross-contamination during vascular access processes. In response, manufacturers are significantly scaling up production capacities to satisfy this regulation-led demand for protective equipment. According to a January 2025 press release titled 'BD Boosts U.S. Manufacturing of Critical Medical Devices,' Becton, Dickinson and Company announced investments to increase their manufacturing capacity for safety-engineered injection devices by over 40 percent to support essential healthcare delivery requirements.

At the same time, there is a clear transition toward developing user-friendly cannulas tailored for home-based care, especially regarding respiratory therapy and long-term infusion. As medical care shifts from hospital settings to patients' homes, there is a rising demand for durable, low-maintenance devices that enable individuals to independently manage chronic issues such as sleep apnea and respiratory distress. This shift toward home care is driving significant revenue increases for specialized device makers. As noted in Fisher & Paykel Healthcare's 'Annual Report 2025' from May 2025, revenue for their Homecare product group, which includes devices for community-based respiratory support, hit approximately $740 million, marking a 13% rise over the prior financial year.

Key Market Players

• Medtronic plc
• Becton Dickinson (BD) & Company
• Edward Lifesciences Corporation
• LivaNovaca plc
• Smiths Medical MD Inc
• Boston Scientific Corporation
• Hindustan Syringes and Medical Devices Ltd (HMD)
• Sterimedix Ltd.
• Angiplast Pvt. Ltd
• Sterimed Group

Report Scope

In this report, the Global Cannula Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cannula Market, By Product

• Cardiac
• Dermatology
• Nasal
• Others

Cannula Market, By Type

• Neonatal Cannulae
• Straight Cannulae
• Winged Cannulae
• Wing With Port
• Winged With Stop Cork

Cannula Market, By Material

• Plastic
• Metal
• Silicone

Cannula Market, By Size

• 14G
• 16G
• 18G
• 20G
• 22G
• 24G
• 26G

Cannula Market, By End-Use Industry

• Hospital
• Ambulatory Surgical Centers
• Others

Cannula Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cannula Market.

Available Customizations:

Global Cannula Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cannula Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Cardiac, Dermatology, Nasal, Others)
  • 5.2.2. By Type (Neonatal Cannulae, Straight Cannulae, Winged Cannulae, Wing With Port, Winged With Stop Cork)
  • 5.2.3. By Material (Plastic, Metal, Silicone)
  • 5.2.4. By Size (14G, 16G, 18G, 20G, 22G, 24G, 26G)
  • 5.2.5. By End-Use Industry (Hospital, Ambulatory Surgical Centers, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Cannula Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Material
  • 6.2.4. By Size
  • 6.2.5. By End-Use Industry
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cannula Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Material
      • 6.3.1.2.4. By Size
      • 6.3.1.2.5. By End-Use Industry
  • 6.3.2. Canada Cannula Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Material
      • 6.3.2.2.4. By Size
      • 6.3.2.2.5. By End-Use Industry
  • 6.3.3. Mexico Cannula Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Material
      • 6.3.3.2.4. By Size
      • 6.3.3.2.5. By End-Use Industry

7. Europe Cannula Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Material
  • 7.2.4. By Size
  • 7.2.5. By End-Use Industry
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cannula Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Material
      • 7.3.1.2.4. By Size
      • 7.3.1.2.5. By End-Use Industry
  • 7.3.2. France Cannula Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Material
      • 7.3.2.2.4. By Size
      • 7.3.2.2.5. By End-Use Industry
  • 7.3.3. United Kingdom Cannula Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Material
      • 7.3.3.2.4. By Size
      • 7.3.3.2.5. By End-Use Industry
  • 7.3.4. Italy Cannula Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Material
      • 7.3.4.2.4. By Size
      • 7.3.4.2.5. By End-Use Industry
  • 7.3.5. Spain Cannula Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Material
      • 7.3.5.2.4. By Size
      • 7.3.5.2.5. By End-Use Industry

8. Asia Pacific Cannula Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Material
  • 8.2.4. By Size
  • 8.2.5. By End-Use Industry
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cannula Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Material
      • 8.3.1.2.4. By Size
      • 8.3.1.2.5. By End-Use Industry
  • 8.3.2. India Cannula Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Material
      • 8.3.2.2.4. By Size
      • 8.3.2.2.5. By End-Use Industry
  • 8.3.3. Japan Cannula Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Material
      • 8.3.3.2.4. By Size
      • 8.3.3.2.5. By End-Use Industry
  • 8.3.4. South Korea Cannula Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Material
      • 8.3.4.2.4. By Size
      • 8.3.4.2.5. By End-Use Industry
  • 8.3.5. Australia Cannula Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Material
      • 8.3.5.2.4. By Size
      • 8.3.5.2.5. By End-Use Industry

9. Middle East & Africa Cannula Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Material
  • 9.2.4. By Size
  • 9.2.5. By End-Use Industry
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cannula Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Material
      • 9.3.1.2.4. By Size
      • 9.3.1.2.5. By End-Use Industry
  • 9.3.2. UAE Cannula Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Material
      • 9.3.2.2.4. By Size
      • 9.3.2.2.5. By End-Use Industry
  • 9.3.3. South Africa Cannula Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Material
      • 9.3.3.2.4. By Size
      • 9.3.3.2.5. By End-Use Industry

10. South America Cannula Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Material
  • 10.2.4. By Size
  • 10.2.5. By End-Use Industry
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cannula Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Material
      • 10.3.1.2.4. By Size
      • 10.3.1.2.5. By End-Use Industry
  • 10.3.2. Colombia Cannula Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Material
      • 10.3.2.2.4. By Size
      • 10.3.2.2.5. By End-Use Industry
  • 10.3.3. Argentina Cannula Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Material
      • 10.3.3.2.4. By Size
      • 10.3.3.2.5. By End-Use Industry

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cannula Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton Dickinson (BD) & Company
• 15.3. Edward Lifesciences Corporation
• 15.4. LivaNovaca plc
• 15.5. Smiths Medical MD Inc
• 15.6. Boston Scientific Corporation
• 15.7. Hindustan Syringes and Medical Devices Ltd (HMD)
• 15.8. Sterimedix Ltd.
• 15.9. Angiplast Pvt. Ltd
• 15.10. Sterimed Group

16. Strategic Recommendations

17. About Us & Disclaimer